The shingles vaccine may offer a protective effect against developing dementia, as well as “therapeutic potential” for those ...

Dynavax stockholders to receive $15.50 in cash, a 39% premium to Dynavax closing share price onDecember 23, 2025 EMERYVILLE, Calif., Dec. 24, 2025 /PRNewswire/ -- ...

Dynavax's adult hepatitis B vaccine HEPLISAV-B is currently marketed in the US and is differentiated by its two-dose regimen over one month, which enables high levels of seroprotection faster than ...

Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris, December 24, 2025. Sanofi announced today that it has entered into an ...

Learn how to get the vaccines you need now to protect yourself from illnesses, including flu, RSV, measles, Covid-19, and ...

If you're over age 50 or have a suppressed immune system, you may have heard your doctor recommend the shingles vaccine. But ...

A majority of primary care physicians understand shingles risk factors, but only 29% are fully aware of current vaccine recommendations. The U.S. Advisory Committee on Immunization Practices has ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? A study published last April found that the likelihood of receiving a dementia ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." A study published last April found that the likelihood of receiving a dementia diagnosis was 20 percent ...

This week's biggest stories include a ground-breaking study from Stanford linking shingles vaccines with lowered dementia risk and Amgen's biotechnology A report from Systemiq reveals that phthalates, ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get the AARP Now app. New and improved, it’s the app that makes ...